메뉴 건너뛰기




Volumn 20, Issue 1, 2012, Pages 6-11

Controversies in behçet disease

Author keywords

Behcet's disease; Clinical; Therapy; Uveitis

Indexed keywords

ADALIMUMAB; ALPHA INTERFERON; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOPLEGIC AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 1 ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYDRIATIC AGENT; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 84856868942     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.649153     Document Type: Article
Times cited : (20)

References (12)
  • 1
    • 0025360899 scopus 로고
    • Criteria for diagnosis of Behçet's disease
    • International Study Group for Behçet's Disease
    • International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078-1080.
    • (1990) Lancet. , vol.335 , pp. 1078-1080
  • 2
    • 0023959626 scopus 로고
    • Revised diagnostic criteria for Behçet's disease in 1987
    • Mizushima Y. Revised diagnostic criteria for Behçet's disease in 1987. Ryumachi. 1988;28:66-70.
    • (1988) Ryumachi. , vol.28 , pp. 66-70
    • Mizushima, Y.1
  • 4
    • 56249131741 scopus 로고    scopus 로고
    • Ocular infammation in Behçet disease: Incidence of ocular complications and of loss of visual acuity
    • Kacmaz RO, Kempen JH, Newcomb C, et al. Ocular infammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146:828-836.
    • (2008) Am J Ophthalmol. , vol.146 , pp. 828-836
    • Kacmaz, R.O.1    Kempen, J.H.2    Newcomb, C.3
  • 5
    • 0033504877 scopus 로고    scopus 로고
    • Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy
    • Kotake S, Higashi K, Yoshikawa K, et al. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology. 1999;106:586-589. (Pubitemid 30191596)
    • (1999) Ophthalmology , vol.106 , Issue.3 , pp. 586-589
    • Kotake, S.1    Higashi, K.2    Yoshikawa, K.3    Sasamoto, Y.4    Okamoto, T.5    Matsuda, H.6
  • 6
    • 33746549075 scopus 로고    scopus 로고
    • CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications - Results of a retrospective analysis of 117 cases
    • DOI 10.1007/s10067-005-0070-8
    • Kötter I, Günaydin I, Batra M, et al. CNS involvement occurs more frequently in patients with Behçets disease under cyclosporine A (CSA) than under other medications: results of a retrospective analysis of 117 cases. Clin Rheumatol. 2006;25:482-486. (Pubitemid 44137619)
    • (2006) Clinical Rheumatology , vol.25 , Issue.4 , pp. 482-486
    • Kotter, I.1    Gunaydin, I.2    Batra, M.3    Vonthein, R.4    Stubiger, N.5    Fierlbeck, G.6    Melms, A.7
  • 7
    • 56749168836 scopus 로고    scopus 로고
    • EUlAR recommendations for the management of Behçet disease
    • Hatemi G, Silman A, Bang D, et al. EUlAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656-1662.
    • (2008) Ann Rheum Dis. , vol.67 , pp. 1656-1662
    • Hatemi, G.1    Silman, A.2    Bang, D.3
  • 8
    • 77955327167 scopus 로고    scopus 로고
    • Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease
    • Deuter CME, Zierhut M, Möhle A, et al. long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum. 2010;62:2796-2805.
    • (2010) Arthritis Rheum. , vol.62 , pp. 2796-2805
    • Deuter, C.M.E.1    Zierhut, M.2    Möhle, A.3
  • 9
    • 56249121565 scopus 로고    scopus 로고
    • Long-term effcacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease
    • Gueudry J, Wechsler B, Terrada C, et al. long-term effcacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol. 2008;146:837-844
    • (2008) Am J Ophthalmol. , vol.146 , pp. 837-844
    • Gueudry, J.1    Wechsler, B.2    Terrada, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.